A
Arnon Nagler
Researcher at Sheba Medical Center
Publications - 1435
Citations - 51740
Arnon Nagler is an academic researcher from Sheba Medical Center. The author has contributed to research in topics: Transplantation & Hematopoietic stem cell transplantation. The author has an hindex of 98, co-authored 1316 publications receiving 44298 citations. Previous affiliations of Arnon Nagler include French Institute of Health and Medical Research & University of Paris.
Papers
More filters
Journal ArticleDOI
Partial response of meningeal myeloma to craniospinal radiotherapy.
Barry M. Brenner,Barry M. Brenner,Arnon Nagler,A. Viener,Rivka Sharon,Rivka Sharon,Anna Carter,Anna Carter +7 more
TL;DR: The patient partially responded to craniospinal irradiation but succumbed to rapidly progressive myeloma 20 weeks following diagnosis of meningeal involvement.
Journal ArticleDOI
Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantation.
Maya Koren-Michowitz,Hannah Maayan,Arie Apel,Noga Shem-Tov,Ronit Yerushalmi,Yulia Volchek,Abraham Avigdor,Abraham Avigdor,Avichai Shimoni,Avichai Shimoni,Arnon Nagler,Arnon Nagler +11 more
TL;DR: Combination therapy with ARA-C and GO after SCT results in short-term disease control and limited toxicity and could be considered for patients who are candidates for further immunotherapy.
Journal ArticleDOI
Natural killer (NK) and T cell-associated surface marker expression following allogeneic and autologous bone marrow transplantation (BMT).
TL;DR: A marked difference was observed in NK and T cell-associated markers following TCD B MT, NTCD BMT, and ABMT, which may indicate the possibility of a common NK andT cell progenitor.
Journal ArticleDOI
Positivity in a modified mixed leukocyte reaction test correlates with molecular HLA-C disparity in prediction of unrelated bone marrow transplantation outcome.
TL;DR: It is concluded that the MMLR test may be a useful tool in the prediction of transplant related complications such as GVHD and GR, post unrelated BMT and, in conjunction with molecular HLA-C typing, may improve unrelated donor selection.
Journal ArticleDOI
Hematopoietic stem cell transplantation for adult patients with isolated NPM1 mutated acute myeloid leukemia in first remission
Xavier Poiré,Myriam Labopin,Emmanuelle Polge,Didier Blaise,Patrice Chevallier,Johan Maertens,Eric Deconinck,Edouard Forcade,Alessandro Rambaldi,Gabriela M. Baerlocher,Tsila Zuckerman,Liisa Volin,Harry C. Schouten,Norbert Ifrah,Mohamad Mohty,Jordi Esteve,Arnon Nagler +16 more
TL;DR: Allo‐SCT using MSD appears as a reasonable transplant option for young patients with iNPM1m AML in CR1, which was followed by worse RI and LFS, but similar OS to both allo-SCT modalities.